Determination of the relationship between CD34+stem cell amount and DMSO in hematopoetic stem cell transplantation

被引:0
|
作者
Meric, Neslihan [1 ,4 ]
Parmaksiz, Ayhan [2 ]
Gulbas, Zafer [3 ]
机构
[1] Kutahya Hlth Sci Univ, Fac Engn & Nat Sci, Dept Mol Biol & Genet, Kutahya, Turkiye
[2] Istanbul Hlth & Technol Univ, Fac Med, Istanbul, Turkiye
[3] Anadolu Hlth Ctr, Bone Marrow Transplantat Ctr, Kocaeli, Turkiye
[4] Kutahya Hlth Sci Univ, Fac Engn & Nat Sci, Dept Mol Biol & Genet, Evliya Celebi Yerleskesi Tavsanli Yolu 10 Km, TR-43100 Kutahya, Turkiye
关键词
DMSO (dimethyl sulfoxide); Hematopoietic stem cell transplantation; (HSCT); Cryopreservation; CD34+SCs count; Apheresis product (AP); PERIPHERAL-BLOOD PROGENITOR; DIMETHYL-SULFOXIDE; HEMATOPOIETIC ENGRAFTMENT; CRYOPRESERVATION; PREDICTOR;
D O I
10.1016/j.trim.2023.101831
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It is important to calculate the CD34+ stem cell (SC) count at the right time in patients with hematological malignancies who will undergo Hematopoietic Stem Cell Transplantation (HSCT). The amount of SC infused into the patient affects the engraftment time and healing process of the patient. In this study, we aimed to compare which of the DMSO-not removed and DMSO-removed samples showed the CD34 + SC amount more accurately as the SC amount determination method after the SC was dissolved after cryopreservation in patients who will undergo HSCT. A total of 22 patients were included in the study. All 22 patients were transplanted from frozen samples using DMSO. After the SC products were dissolved in a 37 degrees C water bath, they were washed 2 times and the amount of CD34+ SC was studied from the samples taken by removing DMSO and without removing DMSO. In the findings, the amounts of CD34+ SC studied with both methods were compared. The increase in the number and percentage of CD34+ SC after DMSO-removed was found to be statistically significant both in terms of difference and proportionally, and the calculated effect sizes also showed that the increase was clinically significant (Cohen's d is between 0.43 and 0.677). After thawing the frozen SCs of the patients who will undergo HSCT, the analysis of CD34+ SCs from which DMSO is removed provides a more accurate calculation of the CD34+ SC amount in the AP.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] Hematopoetic stem cell transplantation in patients with advanced systemic sclerosis
    Blank, N.
    Max, R.
    Hundemer, M.
    Hensel, M.
    Ho, A. D.
    Lorenz, H. M.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 201 - 201
  • [42] How promising is hematopoetic stem cell transplantation in multiple sclerosis?
    Reinhard Hohlfeld
    [J]. Journal of Neurology, 2002, 249 : 1147 - 1149
  • [43] The effect of acute exercise on circulating CD34+stem cell in early and late pubertal boys
    Radom-Aizik, S
    Zaldivar, F
    Wilson, LD
    Eliakim, A
    Cooper, DM
    [J]. FASEB JOURNAL, 2006, 20 (05): : A1404 - A1404
  • [44] Use of natural killer cells in hematopoetic stem cell transplantation
    Passweg, JR
    Stern, M
    Koehl, U
    Uharek, L
    Tichelli, A
    [J]. BONE MARROW TRANSPLANTATION, 2005, 35 (07) : 637 - 643
  • [45] Single stem cell transplantation and CD34 expression before and after stem cell homing.
    Sharkis, SJ
    Neutzel, S
    Collector, MI
    [J]. BLOOD, 2000, 96 (11) : 666A - 666A
  • [46] The Donor Factors Influencing the Amount of CD34+Cells Collected for Peripheral Blood Stem Cell Transplantation
    Yoo, J.
    Jekarl, D.
    Kim, Y.
    [J]. TRANSFUSION, 2016, 56 : 85A - 85A
  • [47] How promising is hematopoetic stem cell transplantation in multiple sclerosis?
    Hohlfeld, R
    [J]. JOURNAL OF NEUROLOGY, 2002, 249 (09) : 1147 - 1149
  • [48] EVALUATION OF ACCURI C6 FLOW CYTOMETER FOR CD34+STEM CELL ENUMERATION
    Loosen, Claire
    Osselaer, Jean-Claude
    Mullier, Francois
    Bailly, Nicolas
    Cornet, Yvan
    Dromelet, Alex
    Neymann, Nicolas
    Chatelain, Bernard
    [J]. ACTA CLINICA BELGICA, 2012, 67 (01): : 72 - 72
  • [49] Hematopoetic stem cell transplantation in children with severe congenital neutropenia
    Yesilipek, Akif
    Uygun, Vedat
    Hazar, Volkan
    Daloglu, Hayriye
    Ozturkmen, Seda Irmak
    Celen, Suna
    Kilic, Suar Caki
    Karasu, Gulsun
    [J]. BONE MARROW TRANSPLANTATION, 2019, 54 : 554 - 554
  • [50] Use of natural killer cells in hematopoetic stem cell transplantation
    J R Passweg
    M Stern
    U Koehl
    L Uharek
    A Tichelli
    [J]. Bone Marrow Transplantation, 2005, 35 : 637 - 643